Redhill Biopharma
RDHL
#11160
Rank
โ‚น0.23 B
Marketcap
โ‚น26.04
Share price
-13.08%
Change (1 day)
-71.77%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น64,869. In 2017 the company made an earnings per share (EPS) of -โ‚น2,31,675 a decrease over its 2016 EPS that were of -โ‚น2,03,874.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,31,67513.64%
2016-โ‚น2,03,8749.12%
2015-โ‚น1,86,83168.01%
2014-โ‚น1,11,204-25.93%
2013-โ‚น1,50,125

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น183.54-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น92.03-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น266.64-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น41.70-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น113.06-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel